SEC ownership of GSK plc

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001131399.

Comparable stake leader

BlackRock, Inc.

Disclosed value leader

DODGE & COX

Comparable rows

50/50

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001131399
Issuer location
London

Ownership snapshot

Top shareholders of GSK plc (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
DODGE & COX
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G 13F Lead comparable stake: 8.9% 13D/G row: BlackRock, Inc. Showing 1-8 of 50 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 8.9%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 8.9%
FMR LLC 5.8%
DODGE & COX 4.3%
Fisher Asset Management, LLC 0.89%
PRIMECAP MANAGEMENT CO/CA/ 0.62%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
8.9%
$6,226,766,199
369,576,114 shares
$0 31 Dec 2024
FMR LLC
13F 13D/G
Company
5.8%
from 13D/G
$3,405,289,251
64,961,641 shares
30 Jun 2026
DODGE & COX
13D/G 13F
Company
4.3%
$9,090,903,298
173,259,068 shares
$0 30 Jun 2026
Fisher Asset Management, LLC
13F
Company
13F
0.89%
$1,872,588,820
35,722,792 shares
30 Jun 2026
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
0.62%
$1,320,044,006
25,182,068 shares
30 Jun 2026
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
0.28%
$597,391,372
11,396,249 shares
30 Jun 2026
JTC Employer Solutions Trustee Ltd
13F
Company
13F
0.21%
$450,315,000
8,592,987 shares
30 Jun 2026
MORGAN STANLEY
13F
Company
13F
0.19%
$401,409,572
7,657,562 shares
30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 15 Sep 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for GSK plc

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .